|
Age (years)
|
59.2 ± 12.7
|
55.1 ± 14.9
|
0.030
|
|
Male (n, %)
|
51 (69.9)
|
230 (64.4)
|
0.374
|
|
BMI (g/m2)
|
29.0 ± 5.1
|
28.2 ± 5.5
|
0.215
|
|
GFR (mL/min)
|
82.3 ± 22.1
|
77.4 ± 22.1
|
0.098
|
|
Smoking (n, %)
|
19 (26.0)
|
105 (29.4)
|
0.561
|
|
Hyperlipedemia (n, %)
|
29 (39.7)
|
140 (39.2)
|
0.935
|
|
Diabetes (n, %)
|
10 (13.7)
|
61 (17.1)
|
0.477
|
|
Hypertension (n, %)
|
32 (43.8)
|
139 (38.9)
|
0.436
|
|
History of coronary disease (n, %)
|
20 (27.4)
|
129 (36.1)
|
0.153
|
|
NYHA class
| | | |
|
Class I - II (n, %)
|
23 (63.9)
|
140 (61.9)
| |
|
Class III - IV (n, %)
|
13 (36.1)
|
86 (38.1)
|
0.823
|
|
CMR variables
| | | |
|
- LV anteroseptal wall thickness (mm)
|
10.8 ± 3.5
|
10.8 ± 4.1
|
0.963
|
|
- LV end diastolic volume index (mL/m2)
|
86.2 ± 40.4
|
97.0 ± 43.2
|
0.051
|
|
- LV mass index (mL/m2)
|
81.3 ± 27.6
|
86.2 ± 28.8
|
0.185
|
|
- LV ejection fraction (%)
|
53.8 ± 19.4
|
48.1 ± 22.2
|
0.045
|
|
- RV end diastolic volume index (mL/m2)
|
63.2 ± 18.2
|
65.8 ± 24.5
|
0.374
|
|
- RV ejection fraction (%)
|
57.7 ± 13.0
|
54.0 ± 15.5
|
0.061
|
|
- Presence of LGE (n, %)
|
41 (56.2)
|
243 (68.1)
|
0.050
|
|
- Total fibrosis (≥ 5 SD threshold) (mL)
|
10.6 ± 14.9
|
12.4 ± 17.9
|
0.440
|
|
- Percentage of fibrosis (≥ 5 SD threshold) (%)
|
9.8 ± 12.9
|
11.1 ± 14.5
|
0.44
|
